Piotr Swat / Shutterstock.com

19 August 2025NewsAmericasLiz Hockley

Roche sues over blockbuster cancer drug as key patent protection expires

In a New Jersey lawsuit, Henlius and Organon are accused of submitting an aBLA for a biosimilar that infringes two dozen patents.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

UK govt sets sights on being AI drug discovery ‘world leader’

13 June 2025 Government unveils £8M OpenBind consortium to lead in AI drug discovery | Project to build world’s largest drug–protein dataset | Backed by new Sovereign AI Unit, Consortium will be based at national synchrotron facility in Oxfordshire.

Takeda, Pfizer, and Sumitomo sue to protect $379m Orgovyx revenue

20 March 2025 Trio files multiple patent infringement lawsuits to protect blockbuster prostate cancer drug | Latest suits target Hetero and Aizant, following similar actions against Apotex, BDR Pharmaceuticals, and CIPLA.

More on this story

UK govt sets sights on being AI drug discovery ‘world leader’

13 June 2025 Government unveils £8M OpenBind consortium to lead in AI drug discovery | Project to build world’s largest drug–protein dataset | Backed by new Sovereign AI Unit, Consortium will be based at national synchrotron facility in Oxfordshire.

Takeda, Pfizer, and Sumitomo sue to protect $379m Orgovyx revenue

20 March 2025 Trio files multiple patent infringement lawsuits to protect blockbuster prostate cancer drug | Latest suits target Hetero and Aizant, following similar actions against Apotex, BDR Pharmaceuticals, and CIPLA.

More on this story

UK govt sets sights on being AI drug discovery ‘world leader’

13 June 2025 Government unveils £8M OpenBind consortium to lead in AI drug discovery | Project to build world’s largest drug–protein dataset | Backed by new Sovereign AI Unit, Consortium will be based at national synchrotron facility in Oxfordshire.

Takeda, Pfizer, and Sumitomo sue to protect $379m Orgovyx revenue

20 March 2025 Trio files multiple patent infringement lawsuits to protect blockbuster prostate cancer drug | Latest suits target Hetero and Aizant, following similar actions against Apotex, BDR Pharmaceuticals, and CIPLA.

More features

Apple Watch revives key medtech feature after import ban

Four firms reach highest tier in WIPR’s 2025 Global Trade Secrets Rankings

Judge overturns Amgen’s $50m damages loss

Weil adds two more litigators from larger rival

Why the PTAB’s new expedited filing dates for AIA petitions is positive

Ninth Circuit revives trade secrets claims in DNA-sequencing spat

Latham steps into dispute over $6bn treatment, replacing Kirkland

Patent pollution: Emissions charter aims to clean up IP